SWP
TXG icon

Stratos Wealth Partners’s 10x Genomics TXG Stock Holding History

Stratos Wealth Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$298K Hold
14,052
– – ﹤0.01% 1325
2025
Q4 		$229K Buy
14,052
+950
+7% +$14.4K ﹤0.01% 1440
2025
Q3 		$153K Buy
+13,102
New +$171K ﹤0.01% 1497

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stratos Wealth Partners's TXG Position: Q1 2026 in Review

Stratos Wealth Partners held its 10x Genomics (TXG) position steady in Q1 2026 at 14,052 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

Stratos Wealth Partners first reported a position in TXG in Q3 2025 and has held it in 3 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Stratos Wealth Partners held 14,052 shares of 10x Genomics worth $298K as of Q1 2026.
  • Stratos Wealth Partners left its 10x Genomics share count unchanged in Q1 2026.
  • 10x Genomics made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #1325 holding.
  • Stratos Wealth Partners first reported a position in 10x Genomics in Q3 2025 and has held it in 3 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.